Gujarat Themis Biosyn Stock Sees 7.0% Increase, Outperforms Sector Average

Gujarat Themis Biosyn, a smallcap pharmaceutical company, saw a 7.0% increase in its stock price on November 19, 2024. This gain was higher than the sector average by 6.85%, indicating a strong performance by the company. The stock has been on a consecutive rise for the past three days, with a total gain of 11.18% during this period.

The stock opened with a gain of 2.69% today and reached an intraday high of Rs 330.3, which is an 8.37% increase from the previous day's closing price. The stock's moving averages are currently higher than the 5-day, 20-day, and 200-day averages, but lower than the 50-day and 100-day averages.

In comparison to the overall market performance, Gujarat Themis Biosyn has outperformed the Sensex by 7.35% in the past 1 day and 1.68% in the past 1 month. This indicates a positive trend for the company's stock and its potential for growth.

MarketsMOJO has given a 'Hold' call for Gujarat Themis Biosyn, suggesting that investors should hold onto their current positions in the stock. This news article is based on factual information and does not include any external data or sources. It is important for investors to conduct their own research and make informed decisions before investing in any company.